These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 2231300)
1. Methodological issues in AIDS clinical trials. Statutory and regulatory framework for drug approval. Burlington DB J Acquir Immune Defic Syndr (1988); 1990; 3 Suppl 2():S4-9. PubMed ID: 2231300 [No Abstract] [Full Text] [Related]
2. Drug approval and AIDS: benefits for the elderly. Rothman DJ; Edgar H Health Aff (Millwood); 1990; 9(3):123-30. PubMed ID: 2227773 [No Abstract] [Full Text] [Related]
3. FDA's proposed regulations to expand access to investigational drugs for treatment use: the status quo in the guise of reform. Rossen BR Food Drug Law J; 2009; 64(1):183-223. PubMed ID: 19998746 [TBL] [Abstract][Full Text] [Related]
4. Second thoughts: do the FDA's responses to a fatal drug trial and the AIDS activist community's doubts about early access to drugs hint at a shift in basic FDA policy? Lovell MC Food Drug Law J; 1996; 51(2):273-94. PubMed ID: 11820202 [No Abstract] [Full Text] [Related]
5. AIDS, activism, and ethics. Rothman DJ; Edgar H Hosp Pract (Off Ed); 1991 Jul; 26(7):135-42. PubMed ID: 2071678 [TBL] [Abstract][Full Text] [Related]
6. The AIDS epidemic and clinical trials. Young FE Acad Med; 1989 Nov; 64(11):660-1. PubMed ID: 2803424 [No Abstract] [Full Text] [Related]
7. Executive summary from the final reports of the National Committee to Review Current Procedures for Approval of New Drugs for Cancer and AIDS. Oncology (Williston Park); 1991 Apr; 5(4):16, 18-9. PubMed ID: 1831034 [No Abstract] [Full Text] [Related]
8. Risk versus risk: decision-making dilemmas of drug regulation in the United States and Germany. Daemmrich A; Krucken G Sci Cult (Lond); 2000 Dec; 9(4):505-34. PubMed ID: 15988846 [No Abstract] [Full Text] [Related]
9. The fast track: federal agencies and the political demand for AIDS drugs. Foreman CH Brookings Rev; 1991; 9(2):30-7. PubMed ID: 10110828 [No Abstract] [Full Text] [Related]
10. AIDS, death, and the drug approval process. Berger JW Am Pharm; 1991 Oct; NS31(10):45, 47. PubMed ID: 1957799 [No Abstract] [Full Text] [Related]
11. Desperation drugs. Frustrated AIDs patients are spurring the FDA to relax the rules of the game. Begley S; Hager M; Wilson L Newsweek; 1989 Aug; 114(6):48-9, 51. PubMed ID: 10293942 [No Abstract] [Full Text] [Related]
12. AIDS, safety, and the drug approval process. Uzych L Am Pharm; 1991 Oct; NS31(10):44, 46. PubMed ID: 1957798 [No Abstract] [Full Text] [Related]
13. A faster track for AIDS drugs? Kosterlitz J Natl J (Wash); 1989 Jul; 21(30):1931. PubMed ID: 10293944 [No Abstract] [Full Text] [Related]
14. FDA approves AIDS drug. Am Pharm; 1992 Sep; NS32(9):13-4. PubMed ID: 1332462 [No Abstract] [Full Text] [Related]
15. AIDS drugs in development. Facts and comparisons. Hosp Pharm; 1993 Feb; 28(2):161, 165-7. PubMed ID: 10125704 [No Abstract] [Full Text] [Related]
16. AIDS and the politics of drug lag. Vogel D Public Interest; 1989; (96):73-85. PubMed ID: 10294053 [No Abstract] [Full Text] [Related]
17. 124 drugs currently in development. AIDS Patient Care STDS; 1998 Feb; 12(2):149. PubMed ID: 11361916 [No Abstract] [Full Text] [Related]
18. US turns blind eye to untested AIDS treatment drug imports. Anderson A; Swinbanks D Nature; 1988 Aug; 334(6181):369. PubMed ID: 2457164 [No Abstract] [Full Text] [Related]
19. Panel recommends changes to expedite approval of cancer, AIDS drugs. Am J Hosp Pharm; 1990 Nov; 47(11):2410, 2413. PubMed ID: 2278248 [No Abstract] [Full Text] [Related]
20. New drug initiatives announced. Ann Pharmacother; 1992 Jun; 26(6):868. PubMed ID: 1611177 [No Abstract] [Full Text] [Related] [Next] [New Search]